British drugmaker GSK (LSE: GSK) reported higher revenue and earnings for both the fourth quarter and full year, reflecting strong demand for HIV and specialty medicines. Fourth-quarter revenue rose 6 ...

The US Department of Health and Human Services (HHS) has sharply expanded its use of artificial intelligence, listing around 450 AI use cases across the department in a newly published fiscal 2025 ...

US generics lobby the Association for Accessible Medicines (AAM) has welcomed passage of Q1/Q2 provisions in recent US ...

UK biotech Levicept, which is focused on the development of LEVI-04, a first-in-class treatment for osteoarthritis (OA), today announced the appointment of James Sandy as chief development officer ...

A group of 42 US states and territories has filed a fresh antitrust lawsuit accusing Swiss pharma Novartis (NOVN: VX) and its former generics unit Sandoz (SIX: SDZ) of colluding to fix prices and ...

Market research group DelveInsight suggests the market for TIGIT inhibitors could expand sharply over the next decade, even ...

US biotech major Amgen announced financial results for the fourth quarter and full year of 2025 after markets closed on ...

Japanese drugmaker Astellas Pharma has announced top-line results from the STARLIGHT 2 Phase III pivotal study for ...

US pharma giant Merck & Co (NYSE: MRK) has announced financial results for the fourth quarter and full year of 2025. Merck’s ...

Cambridge, USA-based precision medicines specialist Relay Therapeutics today announced that the US Food and Drug ...

The UK and Japan have announced a major package of science and technology collaborations, it has been announced.

The Coalition for Epidemic Preparedness Innovations (CEPI) and South Korea’s Samsung Biologics, a contract development and manufacturing organization (CDMO), today announced a partnership to ...